NovoCure Limited logo

NovoCure Limited

NASDAQ:NVCR

Overview | Financials
Company Name NovoCure Limited
Symbol NVCR
Currency USD
Price 22.48
Market Cap 2,432,358,480
Dividend Yield 0%
52-week-range 11.7 - 34.13
Industry Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Asaf Danziger
Website https://www.novocure.com

An error occurred while fetching data.

About NovoCure Limited

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune

Related Stocks

Masimo Corporation logo

Masimo Corporation

MASI

181.31 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

115.02 USD

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

18.32 USD

Repligen Corporation logo

Repligen Corporation

RGEN

146.92 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

49.31 USD

Bruker Corporation logo

Bruker Corporation

BRKR

50.04 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

4.2 USD

Acadia Healthcare Company, Inc. logo

Acadia Healthcare Company, Inc.

ACHC

41.06 USD

Financials

Numbers are in millions USD

Numbers are in millions USD